A Randomised, Single-dose, Double-blind, Placebo-controlled, 5-way Crossover Study to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled Doses of GW642444M With and Without Magnesium Stearate in Asthmatic Patients
Phase of Trial: Phase I
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Vilanterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 25 Mar 2009 Trial phase changed from I/II to I as reported by ClinicalTrials.gov.
- 25 Mar 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 25 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.